Head of Biotech Department at Ehrlich Group
Hadassa Waterman is the head of the biotech department at Ehrlich & Fenster – Ehrlich Group.
Since 2001 Dr Waterman has been involved in the preparation and prosecution of patent applications, specialising in cell biology, bio-informatics, immunology, biochemistry, nanotechnology, medical devices, agrotech and nutrition.
Dr Waterman is involved in drafting and prosecuting patent applications, including opposition procedures, in rendering opinions regarding IP matters in IP due diligence processes, and in devising IP and commercialisation strategies.
Dr Waterman has been involved in the drafting and prosecution of thousands of patent applications and in oppositions and litigation support worldwide. She has also been involved in drafting patentability opinions, freedom-to-operate opinions and infringement opinions.
Dr Waterman continues to be recognised by the world’s leading ranking guides, including as one of the leading women IP practitioners in the Global Top 250 Women in IP 2019 ranking of Managing Intellectual Property. She was also named a Patent Star for the fifth consecutive year in their IP Stars 2019 ranking and was recommended in the Legal 500 ranking of intellectual property: filing and prosecution: patents practitioners.
Dr Waterman holds a BSc in biology from the Hebrew University of Jerusalem and a PhD in molecular biology from the Weizmann Institute of Science. During her academic career, Dr Waterman authored over 15 papers and reviews in the fields of cell biology, biochemistry and molecular biology.